Australia markets close in 4 hours 16 minutes

Inspire Medical Systems, Inc. (INSP)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
145.46-0.36 (-0.25%)
At close: 04:00PM EDT
145.50 +0.04 (+0.03%)
After hours: 06:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.33B
Enterprise value 3.92B
Trailing P/E N/A
Forward P/E 833.33
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.49
Price/book (mrq)7.36
Enterprise value/revenue 5.92
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.31
52-week change 3-54.28%
S&P500 52-week change 323.23%
52-week high 3323.09
52-week low 3123.27
50-day moving average 3155.76
200-day moving average 3179.68

Share statistics

Avg vol (3-month) 3655.53k
Avg vol (10-day) 3460.93k
Shares outstanding 529.71M
Implied shares outstanding 629.78M
Float 829.17M
% held by insiders 11.98%
% held by institutions 1108.40%
Shares short (28 June 2024) 41.62M
Short ratio (28 June 2024) 42.41
Short % of float (28 June 2024) 46.25%
Short % of shares outstanding (28 June 2024) 45.44%
Shares short (prior month 31 May 2024) 41.96M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -2.38%
Operating margin (ttm)-9.28%

Management effectiveness

Return on assets (ttm)-3.58%
Return on equity (ttm)-2.88%

Income statement

Revenue (ttm)660.91M
Revenue per share (ttm)22.45
Quarterly revenue growth (yoy)28.20%
Gross profit (ttm)N/A
EBITDA -32.9M
Net income avi to common (ttm)-15.73M
Diluted EPS (ttm)-0.52
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)441.36M
Total cash per share (mrq)14.85
Total debt (mrq)24.5M
Total debt/equity (mrq)4.16%
Current ratio (mrq)7.93
Book value per share (mrq)19.85

Cash flow statement

Operating cash flow (ttm)34.86M
Levered free cash flow (ttm)4.29M